Loading organizations...
§ Private Profile · New York City, NY, USA
Clinical trial automation platform automates protocol conversion into digital tools for clinical research organizations, reducing errors.
Concordare Trials is a Pittsburgh, Pennsylvania-based healthcare software company that automates the conversion of complex clinical trial protocols into operational digital tools. Originally established in New York City, the platform translates medical documents exceeding 300 pages into standardized treatment checklists, billing grids, consent forms, and patient calendars. By utilizing a universal digital format, the technology reduces the standard six to twelve months required for trial start-up and addresses inefficiencies that account for nearly half of a trial's $22.8 million average initiation cost. Operating on a software-as-a-service business model with subscription plans starting at $3,300 per month, the system mitigates the 13% of protocol deviations caused by manual configuration errors. The enterprise is backed by institutional investors including Innovation Works, AlphaLab, and the NYU School of Medicine. Concordare Trials was founded in 2024 by Zach Sawaged and Nathan Maher.
Concordare Trials has raised $100K across 1 funding round.
Concordare Trials has raised $100K in total across 1 funding round.
Concordare Trials has raised $100K across 1 funding round. Most recently, it raised $100K Seed in February 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 10, 2026 | $100K Seed | AlphaLab | — | Announced |
Concordare Trials has raised $100K in total across 1 funding round.
Concordare Trials's investors include AlphaLab.